[HTML][HTML] Normalization cancer immunotherapy: blocking Siglec-15!

G Cao, Z Xiao, Z Yin - Signal transduction and targeted therapy, 2019 - nature.com
Cancer cells can develop various mechanisms to evade tumorspecific and non-specific
attacks in the TME of solid tumors. 2 Thus, systemic activation of immune systems or even …

[HTML][HTML] Normalization cancer immunotherapy: blocking Siglec-15!

G Cao, Z Xiao, Z Yin - Signal Transduction and Targeted Therapy, 2019 - ncbi.nlm.nih.gov
Cancer cells can develop various mechanisms to evade tumorspecific and non-specific
attacks in the TME of solid tumors. 2 Thus, systemic activation of immune systems or even …

Normalization cancer immunotherapy: blocking Siglec-15!

G Cao, Z Xiao, Z Yin - Signal Transduction and Targeted Therapy, 2019 - europepmc.org
In a recent paper published in Nature medicine, Wang, J., et al. identified Siglec-15 as a new
candidate responsible for adaptive immune resistance and a potential target for …

[引用][C] Normalization cancer immunotherapy: blocking Siglec-15!

G Cao, Z Xiao, Z Yin - Signal transduction and targeted …, 2019 - pubmed.ncbi.nlm.nih.gov
Normalization cancer immunotherapy: blocking Siglec-15! Normalization cancer
immunotherapy: blocking Siglec-15! Signal Transduct Target Ther. 2019 Apr 19;4:10. doi …

Normalization cancer immunotherapy: blocking Siglec-15!

C Guangchao, X Zhiqiang… - Signal Transduction and …, 2019 - search.proquest.com
Cancer cells can develop various mechanisms to evade tumorspecific and non-specific
attacks in the TME of solid tumors. 2 Thus, systemic activation of immune systems or even …

Normalization cancer immunotherapy: blocking Siglec-15!

G Cao, Z Xiao, Z Yin - Signal Transduction and Targeted Therapy, 2019 - europepmc.org
Cancer cells can develop various mechanisms to evade tumorspecific and non-specific
attacks in the TME of solid tumors. 2 Thus, systemic activation of immune systems or even …